About
About Gangnam Stem Cell
Written by Liu Mei-Hua from Hong Kong — a long-form reading of Seoul's regenerative quarter, its rooms, and the culture of travelling for treatment.
Gangnam Stem Cell is written under my own name — Liu Mei-Hua (劉美華), a Hong Kong-based wellness editor — and it covers one subject with deliberate narrowness: how regenerative medicine is actually practised in Seoul's Gangnam clinic quarter, and what it is actually like to travel there from Hong Kong for it. The register is closer to the longer wellness features in Tatler Asia or Monocle than to anything a clinic would publish about itself. I write in British English, in long form, and I revise older pieces when the underlying facts move, which in this category they regularly do. Two things should be understood before reading further. First, I am an editor, not a physician; nothing on this site is medical advice, and every clinical decision belongs in a consultation with a licensed Korean doctor. Second, the site operates within the publisher network of HEIM GLOBAL, a KHIDI-registered Korean medical-tourism facilitator — a commercial relationship disclosed here, in the footer of every page, and again below in plain terms.
Who writes this archive
I am Liu Mei-Hua (劉美華), born and based in Hong Kong, with an editorial career spent in the regional wellness and lifestyle press — the kind of magazine work where one learns to judge an establishment by its rooms rather than its press kit. My reference points are unapologetically local: Lee Garden Three, the reading room at the Mandarin Oriental, the yum cha tables of my childhood. I came to Korean regenerative medicine the way many Hong Kong readers of a certain age do — first as an observer of friends' treatment trips, then as a close reader of the category's claims, and eventually as someone who had compared enough consultation rooms, quoted prices, and recovery itineraries to have something genuinely useful to write down. I write under my own name because the archive's credibility depends on a reader knowing exactly who is making the editorial calls, and because the alternative — the anonymous clinic-adjacent byline — is precisely the convention this site exists to be better than. I keep my Cantonese inserts sparing, once or twice an essay, where the texture genuinely demands it.
What HEIM GLOBAL is and what it does
Gangnam Stem Cell operates within the publisher network of HEIM GLOBAL, a Korean medical-tourism facilitator registered with the Korea Health Industry Development Institute (KHIDI) under registration number A-2026-04-02-06873. KHIDI registration sits within the Ministry of Health and Welfare (MOHW) framework for foreign-patient-attraction institutions, and it carries obligations one should actually read before dismissing as paperwork: documented patient-coordination procedures, multilingual aftercare responsibilities, and disclosed commercial relationships with treating clinics. In plain terms, HEIM GLOBAL is a licensed facilitator. It is not a clinic, it employs no physicians, and it performs no procedures. What it does is connect international patients with vetted Korean practices and manage the coordination layer — interpretation, scheduling, aftercare follow-through — that most clinics do not staff well in English or Cantonese. This archive is one editorial property within that network. The arrangement is disclosed because a reader weighing my editorial judgement is entitled to know where the lights are paid from; the editorial judgement itself is not for sale, a distinction I take up below.
Why Hong Kong is the vantage point
This archive is written from Hong Kong on purpose, not by accident of my address. The Hong Kong reader occupies a particular position in Asian medical travel: close enough to Seoul for a long weekend, fluent in the grammar of luxury hospitality, accustomed to a dense private-dermatology market at home, and therefore difficult to impress with lobby marble alone. Reading Gangnam from Causeway Bay means reading it comparatively — against what a private clinic floor in Central charges and delivers, against what the Department of Health (DH) permits at home versus what Korea's Ministry of Food and Drug Safety (MFDS) permits in Seoul, against the practical arithmetic of flights, recovery hotels, and the days one can plausibly be away. That regulatory and economic contrast is the quiet engine of the whole category: procedures and cell-derived preparations that are restricted, unavailable, or differently priced in a reader's home jurisdiction are accessible in Korea under a domestic framework. I do not argue that either framework is the correct one. I do insist that a reader who boards a flight on the strength of anything written here should understand the regulatory border they are crossing, and I write so that they do.
What the archive covers and does not cover
The coverage runs along four braided lines: regenerative cell therapies as practised in Korea — autologous and allogeneic approaches, stromal vascular fraction, mesenchymal stromal cells, exosome adjuncts; the longevity culture that frames them; the hospitality and travel logistics of moving between Hong Kong and Seoul for treatment; and the recovery culture — quiet walks, unhurried restaurants, hotels that understand a compression garment — that determines whether a treatment trip is tolerable or miserable. Geographically the centre of gravity is the Gangnam quarter: Apgujeong, Cheongdam, Sinsa, the streets around Dosan Park. What the archive does not do is equally deliberate. It does not rank clinics by name — where comparison appears it is categorical, consistent with Korean medical-advertising law. It does not reprint clinic marketing as reportage. It does not pretend that ultrasound lifting, thread lifts, or the broader aesthetic menu are its subject, except where they are sequenced alongside regenerative work in a single Korean itinerary. And it does not compress what is genuinely a multi-day, multi-decision undertaking into listicle shorthand; the essays run long because the decisions do.
How the writing is held to account
On clinical matters I hedge in print the way a careful editor should: patients report, studies suggest, may help. Where I cite literature I cite PubMed-indexed work and regulator-published guidance — MFDS, KHIDI, MOHW, DH — that I have actually read, and where the literature is thin or contested I say so rather than paper over it. I do not invent citations and I do not stage anecdotes. On commercial matters the rule is simpler still: inclusion in these pages is editorial, not paid. Clinics do not buy placement, position, or framing. When clinics write to me — and they do, more each year — I correct demonstrated factual errors: names, addresses, licensure details, published prices. I do not adjust editorial assessments to suit a clinic's preference; a clinic that believes my framing of its cluster is unfair may have its response published alongside the framing, and the reader can weigh both. The asymmetry is the point. Facts are non-negotiable; judgement is the service this archive renders, and judgement that bends to lobbying is worth nothing to the person actually booking the flight.
What I am not
I am not a physician, a nurse, or a clinical scientist, and this archive is not medical advice. It is editorial reportage — a reader's close attention to rooms, regimens, prices, and the people one meets between appointments. Nothing here diagnoses, prescribes, or substitutes for a consultation with a licensed Korean doctor, and nothing here should shorten the list of questions a patient asks in that consultation; if the archive works as intended, it lengthens that list. I am also not a booking agent. Readers who want coordination with a Korean clinic — interpretation, scheduling, aftercare — can be routed to HEIM GLOBAL's KHIDI-registered facilitation service, and that routing is disclosed wherever it occurs. The pages themselves recommend categories and criteria, not named miracle providers, and any page that appears to promise an outcome has been misread: biology does not sign contracts, and neither do I on its behalf.
Editorial board
This archive is published under the editorial board operated by Visit Korea Medical, an English-language Korea medical-tourism directory registered with KHIDI under A-2026-04-02-06873. Editorial decisions are made by named contributing editors who also write for our specialised treatment archives.
“The useful question is rarely which clinic is best. It is which room you would be glad to be sitting in on the third day, when the novelty has worn off.”
Liu Mei-Hua, from the editor's desk
Frequently asked questions
Who writes Gangnam Stem Cell?
Liu Mei-Hua (劉美華), a Hong Kong-based wellness editor, writes the archive under her own name. Every essay carries her byline rather than a generic clinic attribution — a transparency commitment, since readers weighing editorial judgement should know whose it is.
Is Gangnam Stem Cell affiliated with a single clinic?
No. The archive is operated by Sora Media, the publishing arm of HEIM GLOBAL, a KHIDI-registered medical-tourism facilitator (A-2026-04-02-06873). Coverage is editorial; the commercial relationship is disclosed on every page, and no clinic buys placement or framing.
Is the content medical advice?
No. Liu Mei-Hua is an editor, not a physician, and the archive is wellness reportage — rooms, protocols, prices, logistics. Clinical decisions belong in a consultation with a licensed Korean doctor, and the essays are written to improve the questions a patient asks there, not to replace the asking.
Why is the archive written from Hong Kong rather than Seoul?
Because its readership largely travels from Hong Kong and comparable cities, and the useful comparisons — home-clinic pricing, DH versus MFDS regulatory positions, the arithmetic of flights and recovery days — are only visible from the traveller's side of the border. The vantage point is the method.
Why don't the essays rank clinics by name?
Korean medical-advertising law constrains named comparative ranking, and the archive follows it. Where comparison appears it is categorical — tiers, criteria, patterns across the quarter — which is also, editorially, the more honest instrument: clinics change faster than league tables admit.
Does the archive cover skin lifting, threads, or the wider aesthetic menu?
Only where those modalities are sequenced alongside regenerative work in a single Korean itinerary. The archive's subject is regenerative practice — SVF, MSC work, exosome adjuncts — and the travel and recovery culture around it, not the aesthetic category at large.
Can I get a personal clinic recommendation by emailing the editor?
Editorial inclusion is not a personal recommendation. Readers who want clinic-specific coordination can be routed to HEIM GLOBAL's KHIDI-registered facilitation service, which works with vetted Korean practices; the routing, like every commercial relationship on this site, is disclosed.
Do you accept paid placements or sponsored essays?
No. Clinics do not purchase inclusion, position, or favourable framing. Demonstrated factual errors are corrected; editorial assessments are not negotiated. A clinic that disputes a framing may have its response published alongside it.